RWA
TARO

Redhawk Wealth Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Redhawk Wealth Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,886
Closed -$420K – 498
2019
Q1 		$420K Buy
+3,886
New +$387K 0.22% 76

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Redhawk Wealth Advisors's TARO Position: Q2 2019 in Review

Redhawk Wealth Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019, closing a stake of 3,886 shares — an estimated $420K sold.

Redhawk Wealth Advisors first reported a position in TARO in Q1 2019 and held it in 1 quarter. The position peaked at $420K in Q1 2019. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

  • Redhawk Wealth Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2019 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 3,886 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $420K.
  • Redhawk Wealth Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 1 quarter.
  • Redhawk Wealth Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $420K in Q1 2019.
  • 105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.